Study details
Enrolling now
rTMS as Add on Treatment for Substance Use Disorders
Yale University
NCT IDNCT06963476ClinicalTrials.gov data as of Apr 2026
Target enrollment
80
Study length
about 1.1 years
Ages
18–60
Locations
1 site in CT
About this study
Researchers are testing whether rTMS can help people with Alcohol Use Disorder (AUD) or Opioid Use Disorder (OUD). The trial will compare different types of rTMS to see which one works best at reducing substance use.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use repetitive transcranial magnetic stimulation (rTMS) for AUD
- 2.Use repetitive transcranial magnetic stimulation (rTMS) for OUD
Primary goalOpioid use
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low7%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Opioid use
Devices
therapeutic
Body systems
Psychiatry / Mental Health